Latest Insider Transactions at Talkspace, Inc. (TALK)
This section provides a real-time view of insider transactions for Talkspace, Inc. (TALK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Talkspace, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Talkspace, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2022
|
John Charles Reilly Chief Legal Officer, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
39,075
+9.86%
|
$39,075
$1.21 P/Share
|
|
Dec 06
2021
|
John Charles Reilly Chief Legal Officer, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
67,792
+17.5%
|
$0
$0.39 P/Share
|
|
Dec 01
2021
|
Samara H. Braunstein Chief Marketing Officer |
SELL
Other acquisition or disposition
|
Direct |
3,278
-2.65%
|
-
|
|
Dec 01
2021
|
Gil Margolin Chief Technology Officer |
SELL
Other acquisition or disposition
|
Direct |
2,553
-2.06%
|
$5,106
$2.13 P/Share
|
|
Dec 01
2021
|
John Charles Reilly Chief Legal Officer, Secretary |
SELL
Other acquisition or disposition
|
Direct |
1,475
-0.46%
|
$2,950
$2.13 P/Share
|
|
Nov 23
2021
|
Douglas L Braunstein |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+8.1%
|
$2,000,000
$2.08 P/Share
|
|
Oct 26
2021
|
Erez Shachar |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Oct 26
2021
|
Jeffrey Crowe |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Oct 18
2021
|
Erin Boyd Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 18
2021
|
Jennifer Fulk Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,150
+50.0%
|
-
|
|
Oct 18
2021
|
Oren Frank Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
433,125
+20.3%
|
-
|
|
Oct 18
2021
|
Roni Frank Head of Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
123,750
+8.17%
|
-
|
|
Oct 18
2021
|
Mark Hirschhorn President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
247,500
+23.88%
|
-
|
|
Oct 18
2021
|
John Charles Reilly Chief Legal Officer, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
61,875
+19.73%
|
-
|
|
Oct 18
2021
|
Gil Margolin Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,750
+50.0%
|
-
|
|
Oct 18
2021
|
Samara H. Braunstein Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,750
+50.0%
|
-
|
|
Aug 30
2021
|
Charles Berg |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Aug 30
2021
|
Madhu Pawar |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Aug 30
2021
|
Curtis Warfield |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Aug 30
2021
|
Jacqueline E Yeaney |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Aug 30
2021
|
Douglas L Braunstein |
BUY
Grant, award, or other acquisition
|
Direct |
15,384
+50.0%
|
-
|
|
Aug 16
2021
|
Hudson Executive Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
142,500
+0.79%
|
$712,500
$5.3 P/Share
|
|
Aug 13
2021
|
Hudson Executive Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,000
+0.26%
|
$230,000
$5.23 P/Share
|
|
Aug 12
2021
|
Hudson Executive Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,100
+0.01%
|
$10,500
$5.17 P/Share
|
|
Jun 22
2021
|
John Charles Reilly Chief Legal Officer, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
189,887
+50.0%
|
-
|
|
Jun 22
2021
|
Mark Hirschhorn President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
541,467
+50.0%
|
-
|
|
Jun 22
2021
|
Douglas L Braunstein |
BUY
Open market or private purchase
|
Indirect |
5,000,000
+33.0%
|
$50,000,000
$10.0 P/Share
|
|
Jun 22
2021
|
Douglas L Braunstein |
SELL
Other acquisition or disposition
|
Indirect |
10,300,000
-100.0%
|
-
|
|
Jun 22
2021
|
Roni Frank Head of Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
1,267,726
+50.0%
|
-
|
|
Jun 22
2021
|
Roni Frank Head of Clinical Services |
BUY
Grant, award, or other acquisition
|
Indirect |
474,719
+50.0%
|
-
|
|
Jun 22
2021
|
Erez Shachar |
BUY
Grant, award, or other acquisition
|
Indirect |
8,573,437
+50.0%
|
-
|
|
Jun 22
2021
|
Jeffrey Crowe |
BUY
Grant, award, or other acquisition
|
Indirect |
14,702,972
+50.0%
|
-
|
|
Jun 22
2021
|
Oren Frank Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,267,726
+50.0%
|
-
|
|
Jun 22
2021
|
Oren Frank Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
474,719
+50.0%
|
-
|